| Cohort short name |
Cohort full name |
Country |
Illumina BeadChip |
N |
Mean age (min - max) |
Female N(%) |
Reference |
| AIRWAVE |
The Airwave Health Monitoring Study |
UK |
Illumina EPIC chip (850K) |
1,127 |
41 (13 - 65) |
458 (41%) |
[46] |
| EXPOsOMICS 'EPIC CVD' |
The European Prospective Investigation into Cancer and Nutrition - EXPOsOMICS subsample |
Italy |
Illumina 450K BeadChip |
313 |
57 (35 - 75) |
167 (53%) |
[47] |
| EPIC |
The European Prospective Investigation into Cancer and Nutrition |
Italy |
Illumina 450K BeadChip |
1,803 |
53 (35 - 75) |
1,114 (62%) |
[48] |
| ESTHER 1 |
Epidemiological investigations on chances of preventing, recognizing early and optimally treating chronic diseases in an elderly population |
Germany |
Illumina 450K BeadChip |
1,000 |
62 (48 - 75) |
500 (50%) |
[49] |
| ESTHER 2 |
Epidemiological investigations on chances of preventing, recognizing early and optimally treating chronic diseases in an elderly population |
Germany |
Illumina EPIC chip (850K) |
864 |
63 (48 - 75) |
390 (45%) |
[49] |
| KORA |
Cooperative Health Research in the Region of Augsburg (KORA-F4) |
Germany |
Illumina 450K BeadChip |
1,727 |
61 (32 - 81) |
882 (51%) |
[50] |
| MCCS |
Melbourne Collaborative Cohort Study |
Australia |
Illumina 450K BeadChip |
2,817 |
59 (40 - 70) |
1,095 (39%) |
[51] |
| NAS |
Normative aging study |
USA |
Illumina 450K BeadChip |
624 |
72 (55 - 91) |
0 (0%) |
[52] |
| NOWAC |
The Norwegian Women and Cancer Study |
Norway |
Illumina 450K BeadChip |
632 |
56 (47 - 63) |
632 (100%) |
|
| NICOLA |
Northern Ireland Cohort Longitudinal Study of Ageing |
Northern Ireland |
Illumina EPIC chip (850K) |
1,929 |
64 (40 - 96) |
988 (51%) |
[53] |
| RS-Bios |
Rotterdam Study 1,2 |
Netherlands |
Illumina 450K BeadChip |
720 |
68 (52 - 80) |
304 (42%) |
[54] |
| RSIII-1 |
Rotterdam Study 3 |
Netherlands |
Illumina 450K BeadChip |
730 |
60 (46 - 89) |
335 (46%) |
[54] |
| SAPALDIA |
Swiss Study on Air Pollution and Lung Diseases in Adults |
Switzerland |
Illumina 450K BeadChip |
402 |
57 (38 - 81) |
184 (46%) |
[REMOVED HYPERLINK FIELD] [55] |
| SKIPOGH a |
Swiss Kidney Project on Genes in Hypertension |
Switzerland |
Illumina 450K BeadChip |
250 |
51 (26 - 82) |
132 (53%) |
[56] |
| SKIPOGH b |
Swiss Kidney Project on Genes in Hypertension |
Switzerland |
Illumina EPIC chip (850K) |
451 |
54 (25 - 89) |
231 (51%) |
[56] |
| TERRE |
Case-control study of Parkinson’s disease in French farmers (only controls were used) |
France |
Illumina EPIC chip (850K) |
174 |
67 (41 - 76) |
80 (46%) |
[57] |
| TILDA |
The Irish Longitudinal Study on aging |
Ireland |
Illumina EPIC chip (850K) |
490 |
62 (50 - 80) |
246 (50%) |
[58] |
| YFS |
Young Finns Study |
Finland |
Illumina 450K BeadChip |
186 |
44 (34 - 49) |
72 (39%) |
[59] |
